Spots Global Cancer Trial Database for Biomarkers for Diagnosis of Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Biomarkers for Diagnosis of Lung Cancer
Official Title: Biomarkers for Diagnosis of Lung Cancer
Study ID: NCT02050100
Interventions
Study Description
Brief Summary: The study goal is to collect blood samples from individuals at risk for lung cancer in order to identify protein markers for diagnosis of lung cancer in the Chinese population.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China
Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China
The Second Affliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Zhongshan Hospital Fudan University, Shang Hai, , China
Henan province People's hospital, Zheng zhou, , China
Contact Details
Name: Chunxue Bai, M.D, Ph.D.
Affiliation: Zhongshan Hospital Fudan Universit
Role: PRINCIPAL_INVESTIGATOR
Name: Xiaoju Zhang, M.D.
Affiliation: Henan Provincial People's Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Muyun Zhu, M.D.
Affiliation: Northern Jiangsu People's Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Kai Wang, MD
Affiliation: The Second Affliated Hospital of Zhejiang University School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Name: Zuke Xiao, MD
Affiliation: Jiangxi Provincial People's Hopital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
